• Blue Owl Capital recently served as lead investor in Veld Capital’s €355 million (about US$401 million) European asset-backed continuation vehicle, which acquires a diversified portfolio of asset-backed finance assets and includes follow-on capital to support a pipeline of deals.
• This move increases Blue Owl’s exposure to European alternative credit and highlights how its expanding asset-backed finance platform can support fee-generating capital deployment beyond its core US-focused operations.
• We’ll now examine how Blue Owl’s role in Veld’s European continuation vehicle could influence its investment narrative built around private credit expansion.

AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Blue Owl Capital Investment Narrative Recap

To own Blue Owl today, you need to believe in its fee-centric private credit and real assets model, even after a steep share price drawdown and volatile earnings. The Veld Capital continuation vehicle adds European asset-backed exposure, but it does not obviously change the near term picture where fundraising momentum remains the key catalyst and execution across multiple new platforms, funded with high leverage, is a central risk.

The most relevant recent update is Blue Owl’s Q1 2026 result, which showed revenue of US$753.8 million and a higher quarterly dividend of US$0.23 per share. That combination keeps attention on whether fee-related earnings and capital inflows can support the current payout and buybacks, especially as Blue Owl adds vehicles like Veld’s continuation fund on top of its growing alternative credit lineup.

Yet beneath the income story, investors should be aware that rising competition and fee pressure could quietly erode Blue Owl’s economics over time as...

Blue Owl Capital's narrative projects $3.8 billion revenue and $1.0 billion earnings by 2029. This requires 9.6% yearly revenue growth and an earnings increase of about $0.9 billion from $78.8 million today.

Uncover how Blue Owl Capital's forecasts yield a $14.93 fair value, a 57% upside to its current price.

Exploring Other Perspectives

Compared with the baseline view, the most optimistic analysts see Blue Owl’s private credit scale as a major upside catalyst, once modeling revenue of about US$4.1 billion and earnings of roughly US$1.1 billion by 2029, but the Veld deal is a reminder that such bullish paths can be revised as new risks and opportunities emerge, so it pays to weigh several very different scenarios before you decide where you stand.

Explore 9 other fair value estimates on Blue Owl Capital - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Blue Owl Capital research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Blue Owl Capital research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Blue Owl Capital's overall financial health at a glance.

Want Some Alternatives?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.